CSIMarket
 


Mimedx Group Inc   (MDXG)
Other Ticker:  
 

Mimedx Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Mimedx Group Inc in the forth quarter 2023?
Mimedx Group Inc achieved a return on average equity (ROE) of 205.33 % in its forth quarter 2023 a new company high.

ROE has advanced compared to 21.53% in the third quarter 2023, due to net income growth.

Within the Medical Equipment & Supplies industry Mimedx Group Inc achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2023 from 0 to 15.

What is ROE?



Return On Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 58 -3 -19 -31 -37
Return On Equity (TTM) 205.33 % - - - -
MDXG's Total Ranking # 15 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 143 1 -13 -18 -18
Seq. Equity Change 10630.6 % - - - -
Seq. Net Income Change 767.65 % - - - -

Return On Equity Company Ranking
Within: No.
Industry # 0
Sector # 0
Overall # 15

Return On Equity Statistics
High Average Low
205.33 %
-86.15 %
-1283.84 %
(Dec 31 2023)   (Mar 31 2021)





MDXG Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Equity in Millions 143 -18 0 0 34
Y / Y Equity Change - - - - -30.73 %
Net Income in Millions 58 -37 -16 -83 -26
Y / Y Net Income Change - - - - -
Return On Equity 40.8 % - -20025.61 % - -74.36 %





Annual Roe Comment
In 2023 ROE improved to 40.8 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDXG's' Return on Equity at Yahoo Finance
MDXG's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for MDXG's Competitors
Return On Equity for Mimedx Group Inc 's Suppliers
Roe for MDXG's Customers




Companies with similar Return On Equity at Dec 31 2023, within Healthcare Sector ROE
Mimedx Group Inc   205.33 %
Halozyme Therapeutics Inc   204.84 %
Roivant Sciences Ltd   160.44 %
Amgen Inc   103.27 %
Entera Bio Ltd   101.78 %
Profound Medical Corp   91.63 %
Davita Inc   78.94 %
Idexx Laboratories Inc  71.66 %
Medpace Holdings Inc   63.98 %
Voyager Therapeutics Inc   63.89 %
Enzo Biochem Inc  53.73 %
Lantheus Holdings Inc   52.00 %
Johnson and Johnson  48.95 %
Zoetis Inc   48.81 %
National Research Corporation  47.79 %
Eli Lilly And Company  46.98 %
Enzon Pharmaceuticals inc   46.47 %
Tenet Healthcare Corp  46.41 %
Siga Technologies Inc  44.84 %
Elite Pharmaceuticals Inc   42.39 %
Star Equity Holdings Inc   42.21 %


Date modified: 2024-02-29T17:11:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com